Targeting CD137 to enhance the antitumor efficacy of cetuximab by stimulation of innate and adaptive immunity. Kohrt, H., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., Lira, R. R., Troutner, E., Richards, L., Rajapaksa, A., Ostashko, A., Weng, W., Chen, L., Colevas, C., Sunwoo, J., Levy, R. AMER SOC CLINICAL ONCOLOGY. 2013

View details for Web of Science ID 000335419601148